We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021). More...
29 Nov 2021
Illustration

Blood and Saliva Samples Can Be Used to Detect Genetic Markers for Liver Cancer

Doctors examining the markers of liver cancer have found that the disease can be recognized by RNA fragments in saliva and blood. More...
29 Nov 2021
Image: Bone marrow smear from a person with myelodysplastic syndrome showing aberrant morphology and maturation (dysmyelopoiesis), resulting in ineffective blood cell production (Photo courtesy of Melbourne Blood Specialists)

Next-Generation Sequencing Impacts All Aspects of Myelodysplastic Syndrome Care

Myelodysplastic Syndrome (MDS) is a type of blood cancer that affects the bone marrow. It causes low levels of one or more types of blood cells in the blood. MDS is more common in people aged over 70, but it can happen at any age. More...
25 Nov 2021
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most do not know it and that is equivalent to more than 2,300 new cases every year in the UK. More...
24 Nov 2021
Illustration

Same Day DNA Sequencing-Based Test Identifies Secondary Infections in COVID-19 Patients

A same-day test has been shown to successfully identify secondary infections in COVID-19 patients in the intensive care unit (ICU) within hours rather than days. More...
23 Nov 2021
Image: Dr. Lee Harrison and Alex Sundermann load samples for genomic sequencing (Photo courtesy of Nathan Langer/UPMC)

AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings

By coupling machine learning with whole genome sequencing, scientists have greatly improved the quick detection of infectious disease outbreaks within a hospital setting over traditional methods for tracking outbreaks. More...
23 Nov 2021
Image: Molecular model of chymotrypsinogen. Increased levels of chymotrypsinogen B1 (CTRB1) were associated with decreased risk of type I diabetes (Photo courtesy of Wikimedia Commons)

Novel Protein Biomarkers Linked to Risk of Developing Type I Diabetes

A recent study identified three novel circulating proteins associated with type I diabetes risk and that could potentially serve as diagnostic biomarkers for the disease. More...
22 Nov 2021
Visit expo >
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble
New
Fixed Volume Pipettor
Labpette FX

In Other News



Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000 - 2024 Globetech Media.
All rights reserved.
CELLAVISION AB